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MARCHANT (1964) has shown that virgin female mice of the C57B1, IF anid F,
hybrid (C57B1 x IF) genetic types respond differently to breast tumour produc-
tion by 20-methylcholanthrene (MC). The IF mice develop a large number of
breast tumours in a short time. The hybrids do likewise, but they take longer to
appear, while the C57B1 mice develop very few breast tumours with a much
longer latent period.
It is known that the hormonal state ofvirgin mice ofthese genetic types differ,
and also that the ultimate breast tumour response of each type followiilg MC
treatment can be altered by changing the hormonal status of the animal, for
instance by breeding or pseudopregnancy (Marchant, 1961 and 1964). But the
question emerged as to what control, if any, the intrinsic properties of the breast
tissue itself had over the response to MC carcinogenesis.
To study the intrinsic capacity of breast tissue to control tumour induction by
MC it is necessary to subject breast tissue of the 3 genetic types to similar carcino-
genic treatment while in a similar hormonal environment. This could be done by
transplantation of breast tissue of the 3 types to similar F1 hybrid hosts before
carcinogen treatment.
Prehn (1953) attempted an experiment to compare the inherent susceptibility
to tumour induction of the breast from mice of different genetic origin to tumour
induction by mammary tumour agent (MTA). He transplanted large skin
grafts bearing breast tissue from the resistant strain C57B1 and from susceptible
F1 hybrid (C57B1 x BALB/c) mice into F1 hybrid (C57B1 x BALB/c) hosts.
After transplantation the mice were infected with MTA. It was planned to
remove surgically any tumours arising in host mammary glands in order to allow
time for tumours to develop in the grafts. But, due to their large numbers. this
proved largely ineffective. Host mammary tumours together with generalised
lymphoma resulted in the early death of the majority of animals. By this time
no tumours had arisen in C57B1 grafted tissue, but a few occurred in grafted
hybrid tissue and Prehn tentatively suggested that the C57B1 breasts were
intrinsically relatively resistant to breast tumour development.
The development oftechniques for the complete mastectomy and transplainta-
tion of breast tissue in the mouse (Riggott, 1965) provided a means of combatting
the difficulty encountered by Prehn. Hybrid host breast tissue could be elimi-
nated and replaced by breast tissue grafted from either of the parental types of
similar hybrids. The use of 20-methyleholanthrene (MC) as a carciniogenici
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agenit was also preferred to the use of MTA, whose carcinogenlic effectiveness
appears to diminish with the increasing age of the mouse to which it is admini-
stered.
MATERIALS AND METHODS
Mice.-The mouse strains used in this study were IF/Bcr and C57BI/Bcr.
These two strains are MTA-free. Spontaneous tumours, possibly of breast origin,
have arisen in a very small proportion of old virgin IF mice in this laboratory and
have not been observed in breeding IF females or in any C57B1 females. First
generation hybrids between the two strains were derived from C57B1 mothers and
IF fathers. The mice were housed in metal boxes measuring 20 x 28 x 11 cm.
Six mice were maintained in each box throughout the experiment. " Rat and
Mouse Breeding Diet ", (Heygate, Bugbrooke Mills, Northampton) was given in
cube form with water ad libitum.
Mastectomy and breast transplantation. F1 hybrid (C57B1 x IF) females were
mastectomised when 3 weeks old. A few days later, after the completeness of
the mastectomy had been ascertained by examination of whole-mount prepara-
tions of the tissue removed, all the breast tissue from C57B1, IF of similar hybrid
mice was transplanted into the mastectomised hybrids. The techniques used
have been described previously (Riggott, 1965).
Carcinogen treatment. Three months after operation all the mice began to
receive cutaneous applications of 0-5 ml. of olive oil containing 0 5 per cent
(2.5 mg.) of MC. The applications were made at fortnightly intervals and each
was spread over the dorsal and ventral surfaces in 16 drops, 8 drops per surface.
The mice received 8 applications in all, starting at 4 months old.
The mice were inspected regularly for tumours of the breast and skin, and
leukaemic symptoms. They were kept as long as their condition remained good
and were killed when tumours had appeared or their condition deteriorated.
Test for tumour origin. In order to establish the genetic constitution of
tumours arising ostensibly from grafts of C57B1 and IF breast, such tumour
tissue was transplanted subcutaneously into mice of both host and donor type.
If remnants of hybrid breast tissue had been present in some of the host
animals and breast tumours had arisen in such remnants, when this tumour
tissue was transplanted back to hybrid and parent strain recipients, it would be
expected to grow only in hybrids and to be immunologically incompatible with
the parent strain.
The genetic origin of tumours arising in breast-free hybrid female mice bearing
grafted breast from parent strain donors only were tested, since the genetic origin
of tumours raised in mice bearing hybrid breast grafts was not in doubt. Each
specimen of tumour was minced thoroughly in a small volume of sterile saline.
Using a wide bore (16, B.W.G.) hypodermic needle, 2 ml. ofthe tumour suspension
was injected into the flank region ofvirgin female mice. Each tumour suspension
was injected into 3 host-type and 3 donor-type female mice. These animals were
killed when a tumour appeared at the site of injection.
Specimens for histology.-After the above test was performed, the remaining
tumour tissue was fixed in 4 per cent formaldehyde saline and embedded in
paraffin wax. Sections were cut and stained in haematoxylin and eosin.
The skin bearing all other breast tissue was completely removed from the body,
pinned to a cork board and fixed overnight in formol saline. The breast tissue
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was then scraped from the skin and whole-mount preparations were made and
stained in Mayer's haemalum (see Riggott, 1965). The ovaries were fixed in
formol saline, sectioned and stained in haematoxylin and eosin.
RESULTS
Survival.-The survival time, in weeks from the first carcinogen treatment, is
summarised in Table I. The small number of mice dying before the appearance
of the first breast tumour is excluded.
TABLE I.-Survival Time ofMastectomised F1 (C57BI x IF) Mice Grafted
with Breast Tissue and Subsequently Treated with Methylcholanthrene (MC)
Type of Number Survival time in weeks from
grafted of first MC treatment
breast mice , -
Mean Range
C57BI. . . 48 . 36 16-51
IF . . 52 . 38 20-64
F, (C57BI x IF) .51 . 34 16-58
Breast tumours, incidence and rate
The incidence of breast tumours which occurred in each type ofgrafted breast
is summarised in Table II.
TABLE II.-The Incidence of Tumours Developing from 3 Genetic Types of Breast
Grafted in F1 (C57BI x IF) Hosts After Treatment with Methylcholanthrene
Strain of Incidence of
grafted Breast tumour br3ast tumours
breast bearers/survivors (per cent)
C57B1. . . 32/48 . 67
IF . 38/52 . 75
F1 (C57B1 x IF) 36/51 . 71
Fig. 1 shows the specific mortality rate for breast cancer in the host animals.
It was derived by the method ofPilgrim andDowd (1963). This makes allowances
for deaths due to extraneous causes, which can markedly affect such measures as
" Tumour incidence ". The steep fall of the curve indicates that breast tumours
appeared rapidly and consistently in each group immediately after the end of the
carcinogen treatment.
Tumour origin
TABLE IlI.-Result of Testfor Tumour Origin
Number of tumours which grew in
Parent
strain
Type of Number of Number and Parent Hybrid
breast tumours failing to hybrid strain host
graft transplanted grow hosts only only
C57B1 . 27 . 2 . 19 3 3
IF. . 29 . 4 . 23 2 0
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Out of 56 tumours tested, 3 failed to grow in parent strain and grew only in
hybridrecipients. Only these 3 could be suspected ofhaving arisen from remnants
of hybrid host breast tissue. However, since 6 tumours failed to grow in any
recipients, 5 tumours grew only in parent strain recipients (and very few tumours
grew in all their recipients), it would seem justifiable to think that the failure of
the 3 suspected tumours to grow in parent strain recipients was a matter of
chance.
MC treatment
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FIG. 1.-Breast tumour mortality rate in mice with breast grafts of 3 genetic types implanted
into breast-free virgin hybrid females after treatment with MC. (Symbols represent the
strain of origin of the breast tissue).
The presence of supernumerary breasts in a very small proportion ofF1 hybrid
(C57B1 x IF) females, in the 5th region, has been previously reported (Riggott,
1965). Since no special precautions had been taken to remove all host fat pad
from the 5th region, tumours arising in this region were under suspicion ofhaving
arisen from host supernumerary breast. However, examination of whole-mount
preparations of breast from this region showed that only 2 tumours of the 140
occurring in this experiment could have arisen from supernumerary breast tissue.
They could not be regarded as having a significant effect upon the final breast
tumour incidence.
HiBtology of breaat tumours
The great majority oftumours were adenocarcinomata. Squamous metaplasia
was common in varying degrees in the 3 groups of mice. A few sarcomas were
52 56
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recorded. There was little difference in the histological types of tumours between
the 3 groups, as may be seen from a study of Table IV.
TABLE IV.-Distribution of the 3 Main Histological Types of Tumour
According to the Genetic Origin of the Breast in which They were Induced
Type of Total number Adenocarcinoma
breast of tumours with squamous
graft examined Adenocarcinoma metaplasia Sarcoma
C57B1. 41 . 14 . 24 . 3
IF . 47 . 12 . 31 4
F1 (C57B1 X IF) 52 14 . 37 . 1*
* This tumour contained a large area of sarcoma and a small area of adenocarcinoma.
Breast without tumours
Variation in breast morphology was evident from the examination of whole
mounts ofall the breasts without tumours. There was no correlation between the
genetic type of breast tissue and general morphology. Breast tissue from all the
mice showed deformities, the most prominent deformities being large nodules
composed of acinar-like structures or a thickening and widening of the ducts into
grotesque shapes. These distortions occurred with similar frequency in each
genetic type of breast.
Other tumours
Skin tumours occurred in 59 cases out of 151 mice and were most frequently
found in the older animals. A few were papillomas, but most were ulcerating
squamous carcinomas occasionally developing from pre-existing papillomas.
Often they necessitated killing the animal.
" Leukaemia " or lymphomatosis occurred in 3 mice with C57B1 breast grafts,
2 mice with IF grafts and 1 mouse with hybrid grafts.
Ovarian tumours were found in 2 mice with C57B1 grafted breasts, in 2 mice
with IF grafted breasts and in 3 mice with hybrid breasts. They were granulosa-
celled tumours, the larger ones being of the pseudofollicular type and the micro-
scopic tumours being undifferentiated.
Most ovaries without tumours showed atrophy and diffuse luteinisation, but
some had hyalinised corpora lutea. Cysts filled with clear fluid, or haemorrhagic
follicles were sometimes present. Developing follicles were found in very few
ovaries, these being from mice killed early in the experiment.
DISCUSSION
In the present experiment breast tissue of 3 genetic types was exposed to the
same hormonal and carcinogenic environment by transplantation to virgin
hybrid hosts maintaiined under similar conditions before similar carcinogenic
treatment. As shown in Table II, the incidence of tumours arising from the
transplanted breast tissue was similar in all 3 types irrespective of the genetic
origin ofthe breast tissue. Fig. 1 shows that the rate at which animals were killed
from the population for the specific cause of breast cancer was practically the
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same with each of the 3 genetic types of breast tissue. It closely resembles the
rate for intact virgin F1 hybrid (C57B1 x IF) mice, but differs from the parental
strain types (Marchant, 1964).
From these results it is clear that there is no quantitative difference in the
susceptibility of breast tissue of the 3 genetic types to tumour induction by MC
after transplantation to similar hosts. Table IV shows that there was no
qualitative difference either, the distribution of the 3 histological types of tumour
being the same in the 3 genetic types of breast tissue.
The results of the test for tumour origin shown in Table III indicate that the
likelihood of tumours arising in remnants of host breast tissue was negligible.
It would seem that the intrinsic properties of the breast tissue itselfplay little
or no part in determining the susceptibility of a mouse strain to the induction of
breast tumours by MC. This contrasts with evidence obtained from transplanta-
tion experiments with other tissues.
Cowen and Salaman (1957) and Cowan (1958) transplanted large skin grafts
from a resistant (C3H) strain and a susceptible (101) strain to the susceptible
(C3H x 101) F1 hybrid type. When the skin was treated once with DMBA and
subsequent croton oil applications, skin tumours arose only on the susceptible
(101) grafts and not on the resistant (C3H) grafts. They found that the grafting
procedure had no effect on skin tumour production by the agents used and that
the skin retained its donor specificity of either susceptibility or resistance to
DMBA and croton oil treatment.
Heston (1951) and Shapiro and Kirschbaum (1951) showed that, when lung
tissue from resistant and susceptible strains was transplanted into the susceptible
hybrid hosts, the tissue retained the susceptibility to the chemical induction of
tumours which was characteristic of the donor strain. This suggested that the
genes for susceptibility were localised in the lung tissue itself.
This evidence oftransplanted tissues which retain their donor susceptibility to
carcinogenesis contrasts markedly with the present results obtained with breast
tissue, which reacts to carcinogen treatment in a manner similar to the normal
hosts breast tissue.
SUMMARY
Breast tissue from C57B1, IF or F1 (C57B1 x IF) donors was transplanted into
F1 (C57B1 x IF) hosts which had been mastectomised when 3 weeks old. Subse-
quent skin paintings with 20-methylcholanthrene (MC) induced similar numbers
of tumours at similar rates in all 3 types of grafted breast tissue. The response
was similar to that for intact virgin F1 (C57B1 x IF) mice and different from that
for either ofthe parental strains. It would appear, therefore, that environmental
host factors, rather than the intrinsic properties of the grafted breast tissue itself,
play an important part in the response of the latter to carcinogenesis by MC.
This work formed part of a thesis for the degree of Ph.D. in the Faculty of
Medicine of the University of Birmingham.
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course of this work.
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